Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Ovid Therapeutics Inc
(NQ:
OVID
)
1.110
-0.020 (-1.77%)
Streaming Delayed Price
Updated: 12:49 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ovid Therapeutics Inc
< Previous
1
2
3
Next >
Looking Into Ovid Therapeutics's Return On Capital Employed
March 15, 2023
Via
Benzinga
Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2022 Financial Results
March 13, 2023
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics to Present at the 2nd Annual Needham Virtual Neuroscience Forum
March 09, 2023
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Studies Published in Cell Reports Medicine Validate the Potential of Direct KCC2 Activation in Resistant Seizures
March 08, 2023
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics: Q1 Earnings Insights
May 10, 2022
Ovid Therapeutics (NASDAQ:OVID) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Ovid Therapeutics to Present at the 43rd Annual Cowen Healthcare Conference
February 28, 2023
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics Expands Epilepsy Development Expertise with New Appointments
February 08, 2023
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics Dosed Healthy Volunteers with OV329 in Phase 1 Trial
January 05, 2023
A Potential, Next-Generation GABA-Aminotransferase Inhibitor for Rare Epilepsies with Limited Treatment Options
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics to Present Data on Its Epilepsy Programs at American Epilepsy Society Annual Meeting (2022)
December 02, 2022
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
November 08, 2022
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
May 26, 2022
On Thursday, 94 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
May 23, 2022
On Monday, 149 companies reached new 52-week lows.
Via
Benzinga
3 Biotech Stocks Under $10 to Add to Your Buy List
April 26, 2022
These biotech stocks to buy are all profitable, which is important for investors looking to reduce their investment risk.
Via
InvestorPlace
Overview Of Value Stocks In The Healthcare Sector
April 11, 2022
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
February 21, 2022
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 27, 2022
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock increased by 28.7% to $2.24 during Thursday's pre-market session. The company's market cap stands at $31.4...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 27, 2022
Good morning, trader! We're starting off the day with an overview of the biggest pre-market stock movers to watch on Thursday!
Via
InvestorPlace
Ovid Therapeutics Expands Its Anti-Epileptic Franchise With AstraZeneca Licensing Pact
January 03, 2022
Ovid Therapeutics Inc (NASDAQ: OVID) has entered into an exclusive license agreement with AstraZeneca plc (NASDAQ: AZN) for a library of early-stage small...
Via
Benzinga
5 Value Stocks In The Healthcare Sector
December 27, 2021
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
September 13, 2021
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
July 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 08, 2021
Gainers Aytu BioPharma (NASDAQ:AYTU) stock increased by 19.36% to $6.41 during Tuesday's pre-market session. The market value of their outstanding shares is at $161.3...
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
May 24, 2021
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 13, 2021
Gainers Bionano Genomics (NASDAQ:BNGO) st...
Via
Benzinga
Ovid Therapeutics Stops Gaboxadol Development Citing Limited Efficacy In Rare Neurological Conditions
April 19, 2021
Ovid Therapeutics Inc (NASDAQ: OVID) has announced to discontinue the development of OV101 (gaboxadol), a delta (δ)-selective GABAA receptor agonist, in...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2021
April 20, 2021
Upgrades Compass Point upgraded the previous rating for Newtek Business Services Corp (NASDAQ:NEWT) from Neutral to Buy. For the fourth quarter, Newtek Business Services...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.